SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 31 Dec 2023
Last Applicant/ Owned by
Suite 210
Bellaire
TX
77401
Serial Number
86619557 filed on 05th May 2015
Registration Number
5241980 registered on 11th Jul 2017
Correspondent Address
Steven M. Espenshade
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
DNABILIZE
Pharmaceutical preparations containing liposomes for use as drug delivery agents that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of liposomes that facilitate the delivery of pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations containing liposomes for use as drug delivery agents that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of liposomes that facilitate the delivery of pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
First Use Date in General
30th Nov 2016
First Use Date in Commerce
30th Nov 2016
Mark Details
Serial Number
No 86619557
Mark Type
No Service/Collective Mark
Attorney Docket Number
No BPTH003US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Dec 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 31st Dec 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 31st Dec 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 07th Jul 2023 | TEAS SECTION 8 & 15 RECEIVED |
| 11th Jul 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 11th Jul 2017 | REGISTERED-PRINCIPAL REGISTER |
| 08th Jun 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 07th Jun 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 06th Jun 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| 31st May 2017 | TEAS STATEMENT OF USE RECEIVED |